5|00000109|000000000000|0005.001|20170224|1957|00|M|U|920|N|G046312976
5|00000109|000000000000|0005.001|20170225|1957|00|M|U|920|N|G046312976
5|00000109|000000000000|0005.001|20170226|1957|00|M|U|920|N|G046312976
5|00000109|000000000000|0005.001|20170227|1957|00|M|U|920|N|G046312976
5|00000109|201702231545|0007.001|285182|201702231545|8|OFFICE VISIT|92084|207Q00000X
5|00000109|201702231545|0007.001|285182|201702231545|8|OFFICE VISIT|92084|207Q00000X
5|00000109|201702231545|0007.001|285182|201702231545|8|OFFICE VISIT|92084|207Q00000X
5|00000109|201702231545|0007.001|285182|201702231545|8|OFFICE VISIT|92084|207Q00000X
5|00000109|201702231545|0007.001|285182|201702231545|8|OFFICE VISIT|92084|207Q00000X
5|00000109|201702230000|0010.001|285182|20170223|142|72|76|23.71|201702230000|||||98.30||||0|20141017|11.00|0.00|5.0|77.111|170.00
5|00000109|201702230000|0010.001|285182|20170223|142|72|76|23.71|201702230000|||||98.30||||0|20141017|11.00|0.00|5.0|77.111|340.00
5|00000109|201702241107|0020.001|285182|20170223|201702241107|147.00|69.00|97.00|235.00
5|00000109|201702231445|0030.001|285182|20170223|201410171445|900388|NO KNOWN ALLERGIES|3|SPECIFIC ALLERGEN GROUP|||N
5|00000109|201702231545|0040.001|285182|20170223|01|349|SMOKING STATUS2|201702231545|N
5|00000109|201702231545|0040.001|285182|20170223|01|569|SMOKING STATUS4|201702231545|N
5|00000109|201702231545|0050.001|285182|20170223|201702231545|20170223|E78.2|||||
5|00000109|201702231545|0050.001|285182|20170223|201702231545|20170223|N42.89|||||
5|00000109|201702231545|0050.001|285182|20170223|201702231545|20170223|Z00.01|||||
5|00000109|201702231545|0050.001|285182|20170223|201702231545|20170223|Z23|||||
5|00000109|201702231545|0060.001|285182|20170223|IMM|90658||FLU COMMERCIAL 2016-2017||COMPLETED|FLU COMMERCIAL 2016-2017|1|20170223|20170223||||||||||||||||0||15|N|92084|207Q00000X
5|00000109|201702231545|0060.001|285182|20170223|IMM|90715||TDAP||COMPLETED|TDAP|1|20170223|20170223||||||||||||||||0||115|N|92084|207Q00000X
5|00000109|201702231545|0060.001|285182|20170223|LAB|10231|E78.2|MIXED HYPERLIPIDEMIA||ORDERED|COMPREHENSIVE METABOLIC PANEL W/EGFR|||20170223|||||||||ORDERMODULE|20170223||ORD||COMPREHENSIVE METABOLIC PANEL W/EGFR||0|||N|92084|207Q00000X
5|00000109|201702231545|0060.001|285182|20170223|LAB|5363|E78.2|MIXED HYPERLIPIDEMIA||ORDERED|PSA, TOTAL|||20170223|||||||||ORDERMODULE|20170223||ORD||PSA, TOTAL||0|||N|92084|207Q00000X
5|00000109|201702231545|0060.001|285182|20170223|PROC|36415|N42.89|OTHER SPECIFIED DISORDERS OF PROSTATE||ORDERED|ROUTINE VENIPUNCTURE|0||20170223||||||||||20170223||ORD||ROUTINE VENIPUNCTURE||0|||N|92084|207Q00000X
5|00000109|201702231545|0060.001|285182|20170223|PROC|E78.2|N42.89|OTHER SPECIFIED DISORDERS OF PROSTATE||ORDERED|ROUTINE VENIPUNCTURE|0||20170223||||||||||20170223||ORD||ROUTINE VENIPUNCTURE||0|||N|92084|207Q00000X
5|00000109|201702231545|0060.001|285182|20170223|PROC|V20.0XXA|N42.89|OTHER SPECIFIED DISORDERS OF PROSTATE||ORDERED|ROUTINE VENIPUNCTURE|0||20170223||||||||||20170223||ORD||ROUTINE VENIPUNCTURE||0|||N|92084|207Q00000X
5|00000109|201702231545|0060.001|285182|20170223|PROC|Einstein|N42.89|OTHER SPECIFIED DISORDERS OF PROSTATE||ORDERED|ROUTINE VENIPUNCTURE|0||20170223||||||||||20170223||ORD||ROUTINE VENIPUNCTURE||0|||N|92084|207Q00000X
5|00000109|201702231600|0070.001|285182|20170223|201702231601|CBC (INCLUDES DIFF/PLT)|6399|ASSIGNED||201702231600|||AE72F80E390A46AEB627D9C84D3B6A40|0|
5|00000109|201702231600|0070.001|285182|20170223|201702231601|COMPREHENSIVE METABOLIC PANEL W/EGFR|10231|ASSIGNED||201702231600|||AE72F80E390A46AEB627D9C84D3B6A40|0|
5|00000109|201702231600|0070.001|285182|20170223|201702231601|LIPID PANEL|7600|ASSIGNED||201702231600|||AE72F80E390A46AEB627D9C84D3B6A40|0|
5|00000109|201702231600|0070.001|285182|20170223|201702231601|PSA, TOTAL|5363|ASSIGNED||201702231600|||AE72F80E390A46AEB627D9C84D3B6A40|0|
5|00000109|201702231600|0070.001|285182|20170223|201702231601|TSH, 3RD GENERATION|899|ASSIGNED||201702231600|||AE72F80E390A46AEB627D9C84D3B6A40|0|E78.2, J45.20, V20.0XXA
5|00000109|201702241107|0080.001|285182|20170223|201702241107|0.3|BASOPHILS||ASSIGNED|0||||AE72F80E390A46AEB627D9C84D3B6A40
5|00000109|201702241107|0080.001|285182|20170223|201702241107|0.7|BILIRUBIN, TOTAL||ASSIGNED|0||||AE72F80E390A46AEB627D9C84D3B6A40
5|00000109|201702241107|0080.001|285182|20170223|201702241107|0.84|CREATININE||ASSIGNED|0||||AE72F80E390A46AEB627D9C84D3B6A40
5|00000109|201702241107|0080.001|285182|20170223|201702241107|1.14|TSH||ASSIGNED|0||||AE72F80E390A46AEB627D9C84D3B6A40
5|00000109|201702241107|0080.001|285182|20170223|201702241107|1.4|ALBUMIN/GLOBULIN RATIO||ASSIGNED|0||||AE72F80E390A46AEB627D9C84D3B6A40
5|00000109|201702241107|0080.001|285182|20170223|201702241107|104|CHLORIDE||ASSIGNED|0||||AE72F80E390A46AEB627D9C84D3B6A40
5|00000109|201702241107|0080.001|285182|20170223|201702241107|111|EGFR AFRICAN AMERICAN||ASSIGNED|0||||AE72F80E390A46AEB627D9C84D3B6A40
5|00000109|201702241649|0090.001|285182|20170223|20170224|201702241649||E78.2, J45.20, V20.0XXA|12404|M4D|29968|00378395105|TAKE 1 TABLET BY ORAL ROUTE  EVERY DAY|617310|90||F|2|20 MG||
5|00000109|201702241649|0090.001|285182|20170223|20170224|201702241649|||12404|M4D|29968|0037839510512|TAKE 1 TABLET BY ORAL ROUTE  EVERY DAY|617310|90||F|2|20 MG||
5|00000109|201702230000|0100.001|285182|20170223|36415#!|201702230000
5|00000109|201702230000|0100.001|285182|20170223|90471|201702230000
5|00000109|201702230000|0110.001|285182|20170223|DE|01|1653|PE RESPIRATORY|201702230000||
5|00000109|201702230000|0110.001|285182|20170223|DE|01|1654|PE LYMPH DETAIL|201702230000||
5|00000109|201702230000|0110.001|285182|20170223|DE|01|173|MEDS REVIEWED|201702230000||
5|00000109|201702230000|0110.001|285182|20170223|DE|01|214|PSY_MAJORDEPRESSION|201702230000||
5|00000109|201702230000|0110.001|285182|20170223|DE|01|215|PSY_MENTAL STATUS|201702230000||
5|00000109|201702230000|0110.001|285182|20170223|DE|01|268|SYMPTOM_URINARY INCONTINENCE DETAIL|201702230000||
5|00000109|201702230000|0110.001|285182|20170223|DE|01|31|ASSESS_ANGINA_ASSOC_SYMPTOMS|201702230000||
5|00000109|201702230000|0110.001|285182|20170223|DE|01|40|ASSESS_PULSES LE|201702230000||
5|00000109|201702230000|0110.001|285182|20170223|DE|01|46|ASSESS_SENSORY EXAM|201702230000||
5|00000109|201702230000|0110.001|285182|20170223|DE|01|486|FOBT_PE|201702230000||
5|00000109|201702231545|0110.001|285182|20170223|OD|01|54|ASSESS_TYMPANIC MEMBRANE MOBILITY|201702231545|Y|
5|00000109|201702231545|0110.001|285182|20170223|OD|01|762|ANGINA_ASSOC_SYMPTOMS|201702231545|1|
